Cargando…
Transition from Secondary Blood Test to Nucleic Acid Amplification for Safe Allograft Transplantation
BACKGROUND: Given the incubation period of viral diseases, a secondary blood test should be performed at least 3–6 months after the first test to ensure the safety of allogenic bone grafts obtained from living donors in some tissue banks. The allograft is discarded if a secondary blood test was unav...
Autores principales: | Ju, Sunghun, Lee, Choongwoo, Jung, Jiyoung, Jeong, Jinyoung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Orthopaedic Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609207/ https://www.ncbi.nlm.nih.gov/pubmed/34868507 http://dx.doi.org/10.4055/cios21031 |
Ejemplares similares
-
Nucleic acid testing: Is it the only answer for safe Blood in India?
por: Naidu, N. K., et al.
Publicado: (2016) -
History and Future of Nucleic Acid Amplification Technology Blood Donor Testing
por: Roth, Willi Kurt
Publicado: (2019) -
Automated nucleic acid amplification testing in blood banks: An additional layer of blood safety
por: Chigurupati, Pragati, et al.
Publicado: (2015) -
Characteristic of HBV nucleic acid amplification testing yields from blood donors in China
por: Wu, Danxiao, et al.
Publicado: (2021) -
Recent Uses of Paper Microfluidics in Isothermal Nucleic Acid Amplification Tests
por: Reynolds, Jocelyn, et al.
Publicado: (2023)